Clinical trial
Prevalence of Atherosclerotic Disease in Asian Subjects Not on Lipid-lowering Agents, But With at Least Two CVD Risk Factors
NCT00970918 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prevalence of Atherosclerotic Disease in Asian Subjects Not on Lipid-lowering Agents, But With at Least Two CVD Risk Factors
- Lead sponsor
- AstraZeneca
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 31, 2009
- Completion date
- August 31, 2010
- Enrollment
- 2,609 (actual)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.
cardiovascular disease